Total Liabilities: The total value of all possible claims against the corporation.
Edesa Biotech, Inc. (EDSA) had Total Liabilities of $2.15M for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
-- |
|
$-1.86M |
|
-- |
|
-- |
|
$2.22M |
|
$-2.22M |
|
$0.35M |
|
$-1.86M |
|
$-1.86M |
|
$-1.86M |
|
$-1.86M |
|
$-1.86M |
|
$-1.86M |
|
$-2.22M |
|
$-2.18M |
|
3.19M |
|
3.19M |
|
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$4.24M |
|
$0.01M |
|
$2.23M |
|
$6.48M |
|
$2.15M |
|
-- |
|
-- |
|
|
Total Liabilities |
$2.15M |
$4.32M |
|
$2.19M |
|
$4.32M |
|
3.22M |
|
| Cash Flow Statement Financials | |
$-3.07M |
|
-- |
|
$0.52M |
|
$5.36M |
|
$2.80M |
|
$-2.56M |
|
$0.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.07M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-43.04% |
|
-84.80% |
|
-28.75% |
|
-43.04% |
|
$1.34 |
|
$-0.96 |
|
$-0.96 |
|